We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Scanners Market Driven by AI, Cloud and Portable Systems

By HospiMedica International staff writers
Posted on 01 Jun 2019
The global ultrasound market is expected to have achieved revenues of USD 6.12 billion from 115,592 units in 2018, driven by its offer of fusion imaging, wearable ultrasound, and Artificial Intelligence (AI)-powered systems in the established markets and contrast-enhanced ultrasound and elastography in the emerging markets. More...
The cart-based segment dominated the ultrasound market with the highest revenues, accounting for a share of 73.4% and 60.4% of unit shipments.

These are the latest findings of Frost & Sullivan (San Antonio, TX, USA), a provider of research and consulting solutions.

According to the research, the market participants can capitalize on additional growth opportunities by:

-Engaging in cross-functional partnerships across the continuum of equipment management, covering software upgrades and transducer maintenance;
-Augmenting technical support capabilities with onsite engineers, virtual assistance, and online tools;
-Adopting a targeted approach toward emerging application areas like emergency medicine, anesthesia, and primary care;
-Identifying growth markets based on factors such as ease of transition and willingness to use portable or ultra-portable systems;
-Targeting general practitioner (GP) clinics with ultra-portable systems and small hospitals with cart-based systems;
-Developing new business models focusing on operational efficiency and training.

"Globally, emerging segments such as musculoskeletal, anesthesiology, and endocrinology will evolve into established segments by 2023," said Poornima Srinivasan, Industry Analyst, Transformational Health. "AI will be used in premium ultrasound systems, primarily for detecting breast cancer, in ob-gyn settings for fetal image assessment, and in the cardiology domain in the US, Japan, and Western European countries."

"Non-invasiveness, expanding clinical applications, affordability, and introduction of portable and ultra-portable systems, cloud, AI, and other digital capabilities are expected to further drive the growth of ultrasound scanners," added Srinivasan. "Domestic manufacturers will compete against major OEMs on product features, pricing, and servicing, while vendors will compete on value-based products, product miniaturization, and automation."

Related Links:
Frost & Sullivan


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Gas Analyzer
GE SAM
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.